Clinical trials of CAR-T cells in China

Article English OPEN
Liu, Bingshan; Song, Yongping; Liu, Delong;
  • Publisher: BioMed Central
  • Journal: Journal of Hematology & Oncology,volume 10 (issn: 1756-8722, eissn: 1756-8722)
  • Related identifiers: doi: 10.1186/s13045-017-0535-7, pmc: PMC5651613
  • Subject: Rapid Communication | Diseases of the blood and blood-forming organs | RC254-282 | RC633-647.5 | Neoplasms. Tumors. Oncology. Including cancer and carcinogens
    mesheuropmc: human activities

Abstract Novel immunotherapeutic agents targeting tumor-site microenvironment are revolutionizing cancer therapy. Chimeric antigen receptor (CAR)-engineered T cells are widely studied for cancer immunotherapy. CD19-specific CAR-T cells, tisagenlecleucel, have been recen... View more
Share - Bookmark